Anandi Subbian

Anandi Subbian practices at Blessing Hospital in Quincy, Illinois, part of Blessing Health System.

Anandi Subbian's NPI, 1396740197, was assigned on June 17, 2005. Anandi Subbian holds Illinois license 036144332.

Anandi Subbian's primary practice is Blessing Hospital, at 1005 Broadway St, Quincy, IL 62301 in Adams County. The practice phone is (217) 223-1200.

Anandi Subbian's primary practice is Blessing Hospital in Quincy, Illinois, part of Blessing Health System. Anandi Subbian is also affiliated with Memorial Hospital. The medical group on file is Blessing Hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Anandi Subbian practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Anandi Subbian's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Anandi Subbian's licenses on file in 2 states: Illinois and North Carolina.

CMS data shows 338 Medicare services from Anandi Subbian across 5 procedure codes in 2024, for 231 Medicare patients. Medicare paid $30,547 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 231 Medicare patients who saw Anandi Subbian in 2024. The largest group is 75 to 84, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Anandi Subbian's median patient age at 70, with 59% women.

In 2024, Anandi Subbian wrote 142 Medicare Part D claims for 51 patients. 92% of them were for generic drugs. CMS names the drug for 55 of them, across 4 drugs with 11 or more claims each, at $506 in total drug cost. In 2023, CMS named 47 claims across 3 drugs.

Anandi Subbian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Anandi Subbian from 2 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $129.